Uploaded July 2025 | Updated September 2026, 1 week ago
We sat down with Megan Dunham from Jazz Pharmaceuticals, Andrew York from Novo Nordisk, and Rafael Pereira from Appsilon to explore how SCEs have evolved, what’s working (and what’s not), and how teams are approaching implementation across the industry.
It’s a practical conversation for anyone involved in modernizing infrastructure, managing cross-functional change, or designing environments that support clinical data analysis.
We sat down with Megan Dunham from Jazz Pharmaceuticals, Andrew York from Novo Nordisk, and Rafael Pereira from Appsilon to explore how SCEs have evolved, what’s working (and what’s not), and how teams are approaching implementation across the industry.
It’s a practical conversation for anyone involved in modernizing infrastructure, managing cross-functional change, or designing environments that support clinical data analysis.
